Patent · US Active

Monitoring inflammation status

US11953506B2 · kind B2 · utility

0Cited by
1References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 6, 2020
Grant dateApr 9, 2024
Priority date
Expiry dateNov 25, 2041

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7095
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Methods for monitoring inflammation status of a subject comprise determining levels of at least one neutrophil activation marker, or at least three markers, in urine samples taken from the subject at multiple time points, wherein increased levels of the at least one neutrophil activation marker, or at least one of the markers, in a urine sample are indicative of or predictive of an exacerbation of inflammation and/or wherein decreased levels of the at least one neutrophil activation marker, or at least one of the markers, in a urine sample following an increase are indicative or predictive of recovery from, or successful treatment of, an exacerbation of inflammation. Corresponding systems, test kits and computer programs are provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.